Dry Mouth Syndrome (Literature Review)
Modern data on the frequency of occurrence, classifications, options of clinical manifestations, treatment xerostomia are presented article. Xerostomia is iatrogenically and non-iatrogenically manifested in patients for a number of reasons and detectable in 12% of the world’s population and its prevalence in the elderly amounts to as much as 25%. Oncologically, xerostomia remains a problem in patients receiving radiotherapy for malignant tumors of the upper respiratory and digestive tracts. The basis for hyposialia prophylaxis is oral hygiene (that is to prevent and treat caries and fungal superinfection). In more complex cases of significant xerostomia, saliva substitutes are used, which give patients instant functional relief.The special attention is paid to clinical manifestations and a choice of methods of treatment of this disease after radiotherapy. Due to the numerous diseases and states that xerostomia might accompany the issue of therapy of this category of patients isextremely important for medical practitioners of a wide range of specialties: ENT-specialists, dentists, oncologists.